Global Genetic Screening for Carrier Diseases Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Genetic Screening for Carrier Diseases Market Overview

1.1 Genetic Screening for Carrier Diseases Definition

1.2 Global Genetic Screening for Carrier Diseases Market Size Status and Outlook (2019-2032)

1.3 Global Genetic Screening for Carrier Diseases Market Size Comparison by Region (2019-2032)

1.4 Global Genetic Screening for Carrier Diseases Market Size Comparison by Type (2019-2032)

1.5 Global Genetic Screening for Carrier Diseases Market Size Comparison by Application (2019-2032)

1.6 Global Genetic Screening for Carrier Diseases Market Size Comparison by Sales Channel (2019-2032)

1.7 Genetic Screening for Carrier Diseases Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Genetic Screening for Carrier Diseases Market Snapshot

2.2 Global Genetic Screening for Carrier Diseases Market Volume & Revenue (2019-2025)

2.3 Global Genetic Screening for Carrier Diseases Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Genetic Screening for Carrier Diseases Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Genetic Screening for Carrier Diseases Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Genetic Screening for Carrier Diseases Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Genetic Screening for Carrier Diseases Market Segment Analysis by Player

3.1 Global Genetic Screening for Carrier Diseases Sales and Market Share by Player (2023-2025)

3.2 Global Genetic Screening for Carrier Diseases Revenue and Market Share by Player (2023-2025)

3.3 Global Genetic Screening for Carrier Diseases Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Genetic Screening for Carrier Diseases Market Segment Analysis by Type

4.1 Global Genetic Screening for Carrier Diseases Market by Type

4.1.1 NGS

4.1.2 Whole Exome Sequencing

4.1.3 Others

4.2 Global Genetic Screening for Carrier Diseases Sales and Market Share by Type (2019-2025)

4.3 Global Genetic Screening for Carrier Diseases Revenue and Market Share by Type (2019-2025)

4.4 Global Genetic Screening for Carrier Diseases Average Price by Type (2019-2025)

4.5 Leading Players of Genetic Screening for Carrier Diseases by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Genetic Screening for Carrier Diseases Market Segment Analysis by Application

5.1 Global Genetic Screening for Carrier Diseases Market by Application

5.1.1 Couple

5.1.2 Individual

5.2 Global Genetic Screening for Carrier Diseases Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Genetic Screening for Carrier Diseases by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Genetic Screening for Carrier Diseases Market Segment Analysis by Sales Channel

6.1 Global Genetic Screening for Carrier Diseases Market by Sales Channel

6.1.1 Global Genetic Screening for Carrier Diseases Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Genetic Screening for Carrier Diseases Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Genetic Screening for Carrier Diseases Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Genetic Screening for Carrier Diseases by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Genetic Screening for Carrier Diseases Market Segment Analysis by Region

7.1 Global Genetic Screening for Carrier Diseases Market Size and CAGR by Region (2019-2032)

7.2 Global Genetic Screening for Carrier Diseases Sales and Market Share by Region (2019-2025)

7.3 Global Genetic Screening for Carrier Diseases Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Genetic Screening for Carrier Diseases Market Share by Type

7.4.3 North America Genetic Screening for Carrier Diseases Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Genetic Screening for Carrier Diseases Market Share by Type

7.5.3 Europe Genetic Screening for Carrier Diseases Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Type

7.6.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Genetic Screening for Carrier Diseases Market Share by Type

7.7.3 South America Genetic Screening for Carrier Diseases Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Type

7.8.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Genetic Screening for Carrier Diseases Players

8.1 Thermo Fisher Scientific

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Eurofins Scientific

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Illumina

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Invitae

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 MedGenome

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Myriad Genetics

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Roche

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Natera

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 OPKO Health

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 23andMe

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 bioMérieux

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 EKF Diagnostics

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Gene by Gene (myDNA)

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Fulgent Genetics

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 NxGen MDx

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Sonic Genetics

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 My Baby

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 AncestryDNA

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 DiaSorin

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

8.20 Grifols

8.20.1 Company Snapshot

8.20.2 Product/Service Offered

8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.20.4 Recent Developments

8.21 BGI Genomics

8.21.1 Company Snapshot

8.21.2 Product/Service Offered

8.21.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.21.4 Recent Developments

8.22 Chigene

8.22.1 Company Snapshot

8.22.2 Product/Service Offered

8.22.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.22.4 Recent Developments

8.23 Jiajian Medical Testing

8.23.1 Company Snapshot

8.23.2 Product/Service Offered

8.23.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.23.4 Recent Developments

8.24 Genesky

8.24.1 Company Snapshot

8.24.2 Product/Service Offered

8.24.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.24.4 Recent Developments

8.25 Berry Genomics

8.25.1 Company Snapshot

8.25.2 Product/Service Offered

8.25.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.25.4 Recent Developments

8.26 Weihansi Biomedical Technology

8.26.1 Company Snapshot

8.26.2 Product/Service Offered

8.26.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.26.4 Recent Developments

8.27 Annaroad

8.27.1 Company Snapshot

8.27.2 Product/Service Offered

8.27.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.27.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Genetic Screening for Carrier Diseases

9.1 Industrial Chain of Genetic Screening for Carrier Diseases

9.2 Upstream of Genetic Screening for Carrier Diseases

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Genetic Screening for Carrier Diseases

9.3.1 Leading Distributors/Dealers of Genetic Screening for Carrier Diseases

9.3.2 Leading Consumers of Genetic Screening for Carrier Diseases

Chapter 10. Global Genetic Screening for Carrier Diseases Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Genetic Screening for Carrier Diseases Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Genetic Screening for Carrier Diseases Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Genetic Screening for Carrier Diseases (2026-2032)

11.1 Global Genetic Screening for Carrier Diseases Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Genetic Screening for Carrier Diseases Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Genetic Screening for Carrier Diseases Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Genetic Screening for Carrier Diseases Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Genetic Screening for Carrier Diseases Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Genetic Screening for Carrier Diseases Import-Export (2019-2025)

12.2 Europe Genetic Screening for Carrier Diseases Import-Export (2019-2025)

12.3 Asia Pacific Genetic Screening for Carrier Diseases Import-Export (2019-2025)

12.4 South America Genetic Screening for Carrier Diseases Import-Export (2019-2025)

12.5 Middle East & Africa Genetic Screening for Carrier Diseases Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Genetic Screening for Carrier Diseases Demand-Supply (2019-2025)

13.2 Europe Genetic Screening for Carrier Diseases Demand-Supply (2019-2025)

13.3 Asia Pacific Genetic Screening for Carrier Diseases Demand-Supply (2019-2025)

13.4 South America Genetic Screening for Carrier Diseases Demand-Supply (2019-2025)

13.5 Middle East & Africa Genetic Screening for Carrier Diseases Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources